Back to Results
First PageMeta Content
Piperazines / Drug safety / Food and Drug Administration / Rofecoxib / Sulfones / New Drug Application / COX-2 inhibitor / Merck & Co. / Chemistry / Pharmaceutical sciences / Pharmacology


NDA[removed]Merck Research Laboratories Attention: Robert E. Silverman, M.D., Ph.D. Senior Director, Regulatory Affairs Sumneytown Pike
Add to Reading List

Document Date: 2009-03-31 17:12:24

Open Document

File Size: 14,49 KB

Share Result on Facebook
UPDATE